City Therapeutics (CTY) stock

RNAi therapeutics , market cap $1.0B

RNAi therapeutics that silence proteins

Market cap $1.0B

$20.79

+0.10%

As of 7:29 PM ET after-hours, delayed 15+ min · Live for Pro members

Quality Score

New listing

Checks firing

1of 14

Transition

From its high

-12.9%

No 200-day yet

CTY's Quality Score was unchanged on Fri, Oct 23, at 2.

Trading since Oct 16, 2026. 7 trading days so far, so 11 of the 14 chart checks wait for more history.

Follow CTY's trial news. Pro members can get an alert when City Therapeutics files news, and see its trials, share raises, and its CEO's filings.

Get an alert when CTY files news on its trialsSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Key facts on CTY

Key facts on CTY
Latest filing	8-K, Oct 19 Changed its bylaws or fiscal year

CTY catalysts

Coming up

1 past catalyst since 2026, with sizes and sources, for Pro members.Get in free →

What's next for CTY

Its trials

A trial underway: Phase 1, First-in-Human Study of CITY-RBP4 in Healthy Volunteers and STGD1 ParticipantsPhase 1 · Recruiting · 48 people · main data estimated Feb 2028 · NCT07836452

1 more trial, 1 filing, for Pro members.

Dilution on the horizon

No shelf registration or at-the-market program on file in the last three years.

For Pro members: 1 raise and its amount, and the share count against a year ago.

Insiders

Director Robert Nelsen bought 170,000 shares on Oct 19.

From Form 4: open-market buys and sales only.

Get an alert when Andrew Orth buys or sells

For Pro members: every trade, and Andrew Orth’s 2 filings and quotes.

Get an alert when CTY files news on its trialsSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 15 daysANDA decisionIn 15 days · ANDA decisionNRXPNRX PharmaceuticalsPreservative-free ketamineNRXPNRX Pharmaceuticals · $104MPreservative-free ketamineA generic, under FDA review (GDUFA)
In 27 daysFDA decisionIn 27 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $356MDeramiocelFDA decision due (PDUFA)
In 27 daysFDA decisionIn 27 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $933MMolgramostimFDA decision due (PDUFA)

10 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 168 dates, ranked →

Why CTY scores 2

New listingTransition, 1 of 14 chart checks firingWhat the Quality Score means

+1Chart checks 1 of 14 firing right now, one point each
+1Insider trades Arch Venture Partners XII, LLC (10% owner) bought $3.1M on Oct 19, and 1 more filing

No effect today: Long-term trend, Run-up, Size, Profit, Growth, Dilution, Cash flow, Persistence, and News.

What every line is worth, and the reason behind it, on CTY and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 7:29 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Alert me when CTY's Quality Score turns up

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Here is what Pro members see.

The same page for Pro members, on AMD
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on CTY and every other stock.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

CTY has 1 of 14 chart checks firing

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on CTY, and all 14 on every stock.Get in free →

The deep dive on CTY

What it does and how it makes money1 findingFor Pro members1 finding on what CTY does and how it makes money, for Pro members
Who holds and trades it1 finding10% owner Robert Nelsen bought $3.06M of shares on the open market on Oct 19, 2026, the only insider trade in 90 days.Form 4, filed Oct 19, 2026

1 more finding on CTY, each with its source, for Pro membersGet in free →

How CTY ranks in Biotech

CTY is a new listing, ranked from its 22nd trading day.

How CTY ranks in Biotech
1	HALOHalozyme Therapeutics	9/14	21
2	RIGLRigel Pharmaceuticals	9/14	19
3	MEDPMedpace	7/14	19
	CTMXCytomX Therapeutics		Open for its score
	CTNMContineum Therapeutics		Open for its score
	DBVTDBV		Open for its score
	DFTXDefinium Therapeutics		Open for its score
New	CTYCity Therapeutics	1/14	2

CTY share count over time

Offerings, shelves, and splits of CTY, from its filings
From its filings	Filed
Raised $200M in a sale of shares, about 19% of its market value	Oct 16, 2026
Registered shares for sale (S-1)	Sep 24, 2026

Who is trading CTY

CTY insider trades

One insider bought $3.1M across 1 filing in the last 6 months. No open-⁠market sales on record. The newest:

BuyRobert Nelsen$3.1M10% ownerat $18.00 on Oct 19, filed Oct 19

BuyRobert Nelsen10% owner$3.1Mat $18.00 on Oct 19, filed Oct 19

CTY's officers and directors

Officers and directors with a Form 4 in the last 12 months.

John MaraganoreDirector

See insider trades by person

About City Therapeutics

City Therapeutics Inc is a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi) therapeutics designed to silence the expression of disease-relevant proteins. Its current pipeline is focused on indications with unmet medical need, including thromboembolic diseases, Stargardt disease type 1 (Stargardt disease), and anemia of chronic disease.

citytx.com

Listed on Nasdaq on Oct 16, 2026, and is 16% above its $18 offer price now. Its IPO filing and first days

CTY's score card

City Therapeutics (CTY): Quality Score 2, New listing, with its price, on Breakaway — The picture a link to this page shows when it is shared.

Pro members see every line of every stock's score.

What would turn CTY's score around: 1 thing
2 more filings explained, a plain line each
Real-⁠time prices, no delay

BreakawayOct 19Robert Nelsen bought CTY$3.1M at $18.00, filed Oct 19

Alerts are optional.

See CTY's 14 chart checks

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Straight Answers

As of Oct 26, 2026: CTY's Quality Score is 2 (New listing). Insiders bought $3.1M in the last 6 months (Form 4).

Is CTY a good stock to buy? What its Quality Score says

CTY scores 2 today, which Breakaway calls Below Average. It has 1 of 14 chart checks firing. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is CTY's Quality Score?

CTY scores 2 today, which Breakaway calls Below Average (0 to 5). The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind CTY's 2.

Are insiders buying CTY?

One insider bought $3.1M across 1 filing in the last 6 months. No open-⁠market sales on record. The newest is Robert Nelsen, 10% owner, who bought $3.1M on Oct 19.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.